JD Health International Inc.
6618
株式のランク
#1400
JD Health International Inc., functioning as an investment holding entity, runs... JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
株価
$4.98
時価総額
$15.89B
変化（1日）
-2.21%
変化（1年）
-39.77%
国
CN
取引 JD Health International Inc. (6618)
カテゴリー
Healthcare
JD Health International Inc.（6618）の利益
Jun 2026 時点の利益 TTM: $1.07B
JD Health International Inc. の最新の財務報告によると、同社の現在の利益は $1.07B です。2023 年には $380.49M の利益を上げ、これは 2022 年の利益 $100.87M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
JD Health International Inc. の利益の推移（2017 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $1.07B | 62.26% |
| 2024 | $657.16M | 72.71% |
| 2023 | $380.49M | 277.20% |
| 2022 | $100.87M | -171.12% |
| 2021 | $-141.84M | -94.57% |
| 2020 | $-2.61B | 2,080.12% |
| 2019 | $-119.87M | -369.26% |
| 2018 | $44.52M | 13.15% |
| 2017 | $39.34M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $9.87B | 825.69% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 262.46% |
US
|
|
| $687.82M | -35.50% |
SA
|
|
| $1.25B | 16.92% |
BR
|
